Goodwin Procter advised Palleon Pharmaceuticals on the deal. Palleon Pharmaceuticals announced its strategic collaboration agreement with Shanghai Henlius Biotech, Inc. (2696.HK) to develop and commercialize two bifunctional…
Palleon Pharmaceuticals’ Collaboration Agreement with Shanghai Henlius Biotech, Inc.
